Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer.
Clicks: 283
ID: 4986
2013
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
76.0
/100
283 views
226 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #108 of 375 articles by views in Nature
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 375 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Improved sequencing technologies offer unprecedented opportunities for investigating the role of rare genetic variation in common disease. However, there are considerable challenges with respect to study design, data analysis and replication. Using pooled next-generation sequencing of 507 genes implicated in the repair of DNA in 1,150 samples, an analytical strategy focused on protein-truncating variants (PTVs) and a large-scale sequencing case-control replication experiment in 13,642 individuals, here we show that rare PTVs in the p53-inducible protein phosphatase PPM1D are associated with predisposition to breast cancer and ovarian cancer. PPM1D PTV mutations were present in 25 out of 7,781 cases versus 1 out of 5,861 controls (P = 1.12 × 10(-5)), including 18 mutations in 6,912 individuals with breast cancer (P = 2.42 × 10(-4)) and 12 mutations in 1,121 individuals with ovarian cancer (P = 3.10 × 10(-9)). Notably, all of the identified PPM1D PTVs were mosaic in lymphocyte DNA and clustered within a 370-base-pair region in the final exon of the gene, carboxy-terminal to the phosphatase catalytic domain. Functional studies demonstrate that the mutations result in enhanced suppression of p53 in response to ionizing radiation exposure, suggesting that the mutant alleles encode hyperactive PPM1D isoforms. Thus, although the mutations cause premature protein truncation, they do not result in the simple loss-of-function effect typically associated with this class of variant, but instead probably have a gain-of-function effect. Our results have implications for the detection and management of breast and ovarian cancer risk. More generally, these data provide new insights into the role of rare and of mosaic genetic variants in common conditions, and the use of sequencing in their identification.
| Reference Key |
ruark2013mosaicnature
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Ruark, Elise;Snape, Katie;Humburg, Peter;Loveday, Chey;Bajrami, Ilirjana;Brough, Rachel;Rodrigues, Daniel Nava;Renwick, Anthony;Seal, Sheila;Ramsay, Emma;Duarte, Silvana Del Vecchio;Rivas, Manuel A;Warren-Perry, Margaret;Zachariou, Anna;Campion-Flora, Adriana;Hanks, Sandra;Murray, Anne;Ansari Pour, Naser;Douglas, Jenny;Gregory, Lorna;Rimmer, Andrew;Walker, Neil M;Yang, Tsun-Po;Adlard, Julian W;Barwell, Julian;Berg, Jonathan;Brady, Angela F;Brewer, Carole;Brice, Glen;Chapman, Cyril;Cook, Jackie;Davidson, Rosemarie;Donaldson, Alan;Douglas, Fiona;Eccles, Diana;Evans, D Gareth;Greenhalgh, Lynn;Henderson, Alex;Izatt, Louise;Kumar, Ajith;Lalloo, Fiona;Miedzybrodzka, Zosia;Morrison, Patrick J;Paterson, Joan;Porteous, Mary;Rogers, Mark T;Shanley, Susan;Walker, Lisa;Gore, Martin;Houlston, Richard;Brown, Matthew A;Caufield, Mark J;Deloukas, Panagiotis;McCarthy, Mark I;Todd, John A;, ;, ;Turnbull, Clare;Reis-Filho, Jorge S;Ashworth, Alan;Antoniou, Antonis C;Lord, Christopher J;Donnelly, Peter;Rahman, Nazneen; |
| Journal | Nature |
| Year | 2013 |
| DOI |
10.1038/nature11725
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.